One-week therapy with omeprazole, clarithromycin and amoxicillin for eradication of Helicobacter pylori infection

Journal of the College of Physicians and Surgeons Pakistan

Volumn 12, Issue 6, 2002, Pages 338-340

  Khokhar, Nasir ^a  

^a SHIFA INTERNATIONAL HOSPITAL   (Pakistan)

Author keywords

Endoscopy; Gastrointestinal; Helicobacter pylori; Omeprazole; Peptic ulcer

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; DIAZEPAM; ESOMEPRAZOLE; METRONIDAZOLE; MIDAZOLAM; OMEPRAZOLE; PETHIDINE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHUMAN; PAKISTAN; PATIENT COMPLIANCE; PATIENT MONITORING; PEPTIC ULCER; PROSPECTIVE STUDY; TASTE DISORDER; TREATMENT OUTCOME; ULCER HEALING; UPPER GASTROINTESTINAL TRACT;

EID: 0036623169     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rauws EAJ, Van Der Hulstrwm. The management of Helicobacter pylori infection. BMJ 1998; 316: 162-3.
2. Kazi JI, Jafarey NA, Alam SM, Zuberi SJ, Kazi A, Qureshi H, et al. Association of Helicobacter pylori with acid peptic disease in Karachi. J Pakistan Med Assoc 1990; 40: 240-1.
3. Hussain S, Khattack JI. Clinical, biochemical and histopathological correlations of Helicobacter pylori infection in dyspepsia. Pakistan J Helicobacter 1994; 8: 3-13.
4. Hamama-tul-Bushra, Umar M, Khan NY, Latif Z. Helicobacter pylori and chronic gastritis. Pakistan J Gastroenterol 1995; 9: 18-22.
5. Shaikh WM, Sheikh SM, Shah SR, Jatoi N. Prevalence of Helicobacter pylori infection in acid peptic disorders in nothern Sindh, Pakistan. Pakistan J Gastroenterol 1996; 10: 3-6.
6. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.
7. Asia Pacific Consensus Conference on management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 1-12.
8. Latin-American Consensus Conference on Helicobacter pylori infection. Am J Gastroenterol 2000; 95: 2688-91.
9. Sontag SJ, O' Connell S, Schnell T, Chejfec G, Seidel J, Sonnenberg A. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/Amoxicillin/ Clarithromycin. Am J Gastroenterol 2001; 96: 1390-5.
10. Lai KC, Hui WM, Wong WM, Wong BC, HU WH, Ching CK, et al. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage - a long term randomized, controlled study. Am J Gastroenterol 2000; 95: 2225-32.
11. Qureshi H, Ahmed W, Zuberi SJ. Triple therapy in duodenal ulcer healing - a follow-up study. IPMA 1996; 46: 194-5.
12. Khokhar N. An update on Helicobacter pylori. diagnosis and management. Pakistan J Med Sci 2001; 17: 116-20.
13. Kiyota K, Habu Y, Sugano Y, Inokuchi H, Mizuno S, Kimoto K, et al. Comparison of 1-week and 2-week triple therapy with Omeprazole, Amoxicillin and Clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial. J Gastroenterol 1999; 34 (supp 11): 76-9.
14. Miwa HC, Nagahara A, Sato K, Ohkura R, Murai T, Shimizu H, et al. Efficacy of 1-week Omeprazole or Lansoprazole - Amoxicillin - Clarithromycin therapy for Helicobacter pylori infection in the Japanese population. J Gastroenterol Hepatol 1999; 14: 317-21.
15. Sung JJ, Chung SC, Ling TK, Yung MY, Cheng AF, Hosking SW, et al. One year follow-up of duodenal ulcer after 1-week triple therapy for Helicobacter pylori. Am J Gastroenterol 1994; 89: 199- 202.
16. Wong BC, Chang FY, Abid S, Abbas Z, Lin BR, Van Rensburg C, et al. Triple therapy with Clarithromycin, Omeprazole and Amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa. Aliment Pharmacol Ther 2000; 14: 1529-35.
17. Soll AH. Medical treatment of peptic ulcer disease. Practice Parameters Committee of the American College of Gastroenterology. JAMA 1996; 275: 622-29.
18. Huren Kamp GJ, Van Der Ende A, Grundmeijer HG, Tytgat GN, Van Der Hulst RW. Equally high efficacy of 4,7 and 10 days triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease. Aliment Pharmacol Ther 2000; 14: 1065-70.
19. Lind T, Megravd F, Unge P, Bayerdorffer E, O'Morain C, Spiller R, et al. The MACH-2 study: role of Omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999; 116: 248-53.
20. Savarino V, Zentilin P, Bisso G, Pivari M, Mele MR, Mela GS, et al. Head to head comparison of 1-week, triple regimens combining ranitidine or Omeprazole with two antibiotics to eradicate Helicobacter pylori. Aliment Pharmacol Ther 1999; 13: 643-9.
21. Adamek RJ, Suerbaum S, Pfaffenbach B, Opferkuch W. Primary and acquired Helicobacter pylori resistance to Clarithromycin, Metronidazole and Amoxicillin influence on treatment outcome. Am J Gastroenterol 1998; 93: 386-9.
22. Maconi G, Parente F, Russo A, Vagol L, Imbesi V, Porro GB. Do some patients with Helicobacter pylori infection benefit from an extention to 2-weeks of a proton pumb inhibitor-based triple eradication therapy. Am J Gastroenterol 2001; 96: 359-66.
23. Laine L, Fennerty B, Osato M, Sugg J, Suchower L, Probst P, et al. Esomeprazole-based Helicobacter pylori eradication therapy and efects of antibiotic resistance: results of three US multicenter, double blind trials. Am J Gastroenterol 2000; 95: 3393-8.
24. Monteiro L, Mascarel AD, Sarrasqueta AM, Bergey B, Barberis C, Talby P, et al. Diagnosis of Helicobacter pylori infection: non-invasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol 2001; 96: 353-8.